| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6826215 | Schizophrenia Research | 2013 | 8 Pages |
Abstract
Patients treated with Quetiapine had a higher risk of treatment discontinuation in the short-term after a first episode due to insufficient efficacy. Establishing differences between SGAs may help clinicians in prescribing decisions for the treatment of individuals presenting with first-episode schizophrenia.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Benedicto Crespo-Facorro, Victor Ortiz-GarcÃa de la Foz, Ignacio Mata, Rosa Ayesa-Arriola, Paula Suarez-Pinilla, Elsa M. Valdizan, José Luis Vázquez-Barquero, RocÃo Pérez-Iglesias,